LB-DTK-COV19

BIOLOGICAL2 trials

Sponsors

LucasBio

Conditions

COVID-19COVID-19 (SARS-CoV-2 Infection)

Phase 1

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

Active, not recruitingNCT07709637

LucasBioCOVID-19, COVID-19 (SARS-CoV-2 Infection)

Start: 2025-07-31End: 2026-10-31Updated: 2026-08-26

Unknown Phase

Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 Patients

CompletedNCT07690943

LucasBioCOVID-19, COVID-19 (SARS-CoV-2 Infection)

Start: 2023-06-08End: 2025-01-22Updated: 2026-07-08